Mireille Mousseau

2.9k total citations · 1 hit paper
40 papers, 1.5k citations indexed

About

Mireille Mousseau is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mireille Mousseau has authored 40 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 12 papers in Molecular Biology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mireille Mousseau's work include Cancer Treatment and Pharmacology (13 papers), HER2/EGFR in Cancer Research (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Mireille Mousseau is often cited by papers focused on Cancer Treatment and Pharmacology (13 papers), HER2/EGFR in Cancer Research (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Mireille Mousseau collaborates with scholars based in France, Luxembourg and United States. Mireille Mousseau's co-authors include Bernard Escudier, Jean‐Yves Douillard, J. Savary, A. Mercatello, Christine Lasset, Christine Chevreau, Thierry Philip, Alain Ravaud, J Pény and Sylvie Négrier and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Mireille Mousseau

37 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma

1998 742 citations Mireille Mousseau et al. profile →

Peers

Mireille Mousseau

ONCOL

PRM

SURGE

Eijiro Nakamura Japan

Jianqing Lin United States

Magdolna Dank Hungary

Jie Jin China

Christos Vaklavas United States

Gary J. Smith United States

K. Syrigos Greece

Badar M. Mian United States

Dale R. Shepard United States

Katsunori Tatsugami Japan

Eijiro Nakamura Japan

Mireille Mousseau

574 ×0.9

ONCOL

512 ×0.8

472 ×0.7

PRM

241 ×0.7

233 ×1.0

SURGE

Citations per year, relative to Mireille Mousseau Mireille Mousseau (= 1×) peers Eijiro Nakamura

Countries citing papers authored by Mireille Mousseau

Since Specialization

Citations

This map shows the geographic impact of Mireille Mousseau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mireille Mousseau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mireille Mousseau more than expected).

Fields of papers citing papers by Mireille Mousseau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mireille Mousseau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mireille Mousseau. The network helps show where Mireille Mousseau may publish in the future.

Co-authorship network of co-authors of Mireille Mousseau

This figure shows the co-authorship network connecting the top 25 collaborators of Mireille Mousseau. A scholar is included among the top collaborators of Mireille Mousseau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mireille Mousseau. Mireille Mousseau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vitte, Anne-Laure, Florent Chuffart, Emmanuelle Jacquet, et al.. (2025). Discovery of epigenetically silenced tumour suppressor genes in aggressive breast cancer through a computational approach. NAR Cancer. 7(2). zcaf020–zcaf020.

Jacquet, Emmanuelle, Florent Chuffart, Anne-Laure Vitte, et al.. (2023). Aberrant activation of five embryonic stem cell-specific genes robustly predicts a high risk of relapse in breast cancers. BMC Genomics. 24(1). 463–463. 4 indexed citations

Fourneret, P., et al.. (2018). Prévalence de la douleur en radiothérapie et amélioration de sa prise en charge. Bulletin du Cancer. 105(12). 1183–1192. 4 indexed citations

Nagy-Mignotte, Hélène, Lucile Vignoud, Pascale Guillem, et al.. (2014). Prognostic Impact of Paraneoplastic Cushing’s Syndrome in Small-Cell Lung Cancer. Journal of Thoracic Oncology. 9(4). 497–505. 35 indexed citations

Poncet, Bénédicte, Cyrille Colin, Thomas Bachelot, et al.. (2009). Treatment of Metastatic Breast Cancer. American Journal of Clinical Oncology. 32(4). 369–374. 15 indexed citations

Gauchez, Anne‐Sophie, et al.. (2009). Evaluation of a manual ELISA kit for determination of HER2/neu in serum of breast cancer patients.. PubMed. 28(5B). 3067–73. 7 indexed citations

Gauchez, Anne‐Sophie, et al.. (2006). Prospect for anti-HER2 receptor therapy in breast cancer.. PubMed. 26(1B). 463–22. 26 indexed citations

André, Thierry, Christophe Tournigand, Emmanuel Achille, et al.. (2006). Traitement adjuvant du cancer du côlon : principaux résultats de l’étude MOSAIC*. Bulletin du Cancer. 93(2). 5–9. 1 indexed citations

Delozier, T., Jean‐Paul Guastalla, Alejandro Yovine, et al.. (2006). A phase II study of an oxaliplatin/vinorelbine/5-fluorouracil combination in patients with anthracycline-pretreated and taxane-pretreated metastatic breast cancer. Anti-Cancer Drugs. 17(9). 1067–1073. 12 indexed citations

10.

André, Thierry, Christophe Tournigand, Emmanuel Achille, et al.. (2006). [Adjuvant treatment of colon cancer MOSAIC study's main results].. PubMed. 93 Suppl 1. S5–9. 36 indexed citations

11.

Borget, Isabelle, Anne Aupérin, Jean‐Pierre Pignon, et al.. (2006). Cost-Effectiveness Analysis of First-Line Chemotherapies in Metastatic Colorectal Cancer. Oncology. 71(1-2). 40–48. 3 indexed citations

12.

Mousseau, Mireille, Henri Faure, Isabelle Hininger‐Favier, Mathilde Bayet‐Robert, & Alain Favier. (2005). Leukocyte 8-oxo-7,8-dihydro-2′-deoxyguanosine and comet assay in epirubicin-treated patients. Free Radical Research. 39(8). 837–843. 6 indexed citations

13.

Rebischung, Christine, R Barnoud, Laëtitia Stefani, Jean‐Luc Faucheron, & Mireille Mousseau. (2005). The effectiveness of trastuzumab (Herceptin) combined with chemotherapy for gastric carcinoma with overexpression of the c-erbB-2 protein. Gastric Cancer. 8(4). 249–252. 44 indexed citations

14.

Boutonnât, Jean, et al.. (2004). Non-toxic and short treatment with gemcitabine inhibits in vitro migration of HT-1080 cells. Anti-Cancer Drugs. 15(8). 803–807. 2 indexed citations

15.

Chauvin, Christiane, et al.. (2001). Rotenone Inhibits the Mitochondrial Permeability Transition-induced Cell Death in U937 and KB Cells. Journal of Biological Chemistry. 276(44). 41394–41398. 120 indexed citations

16.

Ychou, Marc, Jean-Yves Douillard, Philippe Rougier, et al.. (2000). Randomized Comparison of Prophylactic Antidiarrheal Treatment Versus No Prophylactic Antidiarrheal Treatment in Patients Receiving CPT-11 (Irinotecan) for Advanced 5-FU-Resistant Colorectal Cancer. American Journal of Clinical Oncology. 23(2). 143–148. 22 indexed citations

17.

Boutonnât, Jean, Magali Barbier, Cécile Rousselle, et al.. (1998). Usefulness of PKHs for studying cell proliferation. Comptes Rendus de l Académie des Sciences - Series III - Sciences de la Vie. 321(11). 901–907. 9 indexed citations

18.

Vuillez, Jean‐Philippe, et al.. (1997). Evaluation of the diagnosis usefulness of OC125 immunoscintigraphy for ovarian carcinomas follow-up after treatment: contribution of this technique in the CHU of Grenoble. Bulletin du Cancer. 84(11). 1 indexed citations

19.

Faure, Henri, Charles Coudray, Mireille Mousseau, et al.. (1996). 5-Hydroxymethyluracil excretion, plasma tbars and plasma antioxidant vitamins in adriamycin-treated patients. Free Radical Biology and Medicine. 20(7). 979–983. 62 indexed citations

20.

Coudray, Charles, et al.. (1995). Lipid peroxidation products, and vitamin and trace element status in patients with cancer before and after chemotherapy, including adriamycin. Biological Trace Element Research. 47(1-3). 117–123. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact